Advertisement

Topics

"If Teva hasn't hit bottom, it's close"

15:49 EDT 3 Aug 2017 | Globes

Excellence Nessuah Brokerage Services senior analyst Gilad Alper says the market may have overreacted to Teva's financials, but advises waiting till all the bad news is out.

Original Article: "If Teva hasn't hit bottom, it's close"

NEXT ARTICLE

More From BioPortfolio on ""If Teva hasn't hit bottom, it's close""

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...